In our previous study, β-caryophyllene oxide was found to produce chemosensitizing effects towards sorafenib in hepatocellular carcinoma cells by inhibiting the efflux through MDR1 (P-gp), MRP1 and MRP2 pumps [16]. The gene discussed is PGP; the disease is hepatocellular carcinoma.